CB CAR-NK182
/ Hangzhou Rongu Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
January 27, 2026
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
(clinicaltrials.gov)
- P1 | N=10 | Completed | Sponsor: Zhejiang Provincial People's Hospital | Trial completion date: Sep 2025 ➔ Dec 2025
Trial completion date • Gastric Cancer • Oncology • Pancreatic Cancer • Solid Tumor • CLDN18
December 11, 2025
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
(clinicaltrials.gov)
- P1 | N=10 | Completed | Sponsor: Zhejiang Provincial People's Hospital | Recruiting ➔ Completed | N=30 ➔ 10 | Trial completion date: Jun 2027 ➔ Sep 2025
Enrollment change • Trial completion • Trial completion date • Gastric Cancer • Oncology • Pancreatic Cancer • Solid Tumor
July 31, 2024
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Zhejiang Provincial People's Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Gastric Cancer • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Solid Tumor
June 18, 2024
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Zhejiang Provincial People's Hospital
Metastases • New P1 trial • Gastric Cancer • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Solid Tumor
1 to 4
Of
4
Go to page
1